Gabbay and colleagues [137] suggested that as an adjunctive therapy with insulin, 2000 IU daily supplementation of vitamin D3 slowed the decline of residual β cell function in patients with new-onset T1D. Here, INS is linked to type 1 diabetes mellitus.